◀ Back to CXCL10
CXCL10 — CXCL5
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Schuh et al., J Immunol 2002
(Asthma...) :
Interestingly, at day 3 after conidia, neutrophil recruitment and airway hyperresponsiveness in CXCR2-/- mice was
mediated by inflammatory
protein-10/CXCL10 and, to a lesser degree,
MIG/CXCL9
Sharma et al., Molecular cancer 2003
(Carcinoma, Lewis Lung) :
In vivo depletion of
IP-10/CXCL10 ,
MIG/CXCL9 or IFNgamma significantly
reduced the anti-tumor efficacy of SLC/CCL21
Kalwitz et al., Int J Biochem Cell Biol 2009
:
Induction of differentially expressed chemokines CXCL1-3,
CXCL5 , and CXCL6 as well as LIF and gp130 in MSC by
CXCL7 was verified by real-time polymerase chain reaction
McKimmie et al., Biochem Biophys Res Commun 2010
:
Bacterial associated molecules
induced the preferential expression of CCL2,
CXCL1 , CCL20 and CCL3 whilst a virus associated dsRNA analogue preferentially up-regulated
CXCL10 and CCL5
Maity et al., Cytokine 2011
:
For example,
CXCL8 expression was markedly
enhanced ( p < 0.05 ) whereas
CXCL5 expression was significantly repressed ( p < 0.05 ) in cells exposed to HS coincident with TNFa stimulation
Geluk et al., J Immunol 2011
(Leprosy) :
Most CD8 ( + ) T cells produced IFN-?, but distinct IFN-? ( + ) /TNF-a ( + ) populations were detected simultaneously with significant secretion of
CXCL10/IFN-? induced protein 10,
CXCL9/MIG , and VEGF